Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;35:367-372

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crews, J. K.
Right arrow Articles by Khalil, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crews, J. K.
Right arrow Articles by Khalil, R. A.
Related Collections
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Hypertension - basic studies
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2000;35:367.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Decreased Endothelium-Dependent Vascular Relaxation During Reduction of Uterine Perfusion Pressure in Pregnant Rat

Janice K. Crews; Jason N. Herrington; Joey P. Granger; Raouf A. Khalil

From the Department of Physiology and Biophysics and Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson.

Correspondence to Raouf A. Khalil, MD, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216. E-mail rkhalil{at}physiology.umsmed.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—Reduction in uterine perfusion and the ensuing placental ischemia during late pregnancy have been proposed to trigger increases in systemic vascular resistance and pregnancy-induced hypertension; however, the intermediary mechanisms involved are unclear. The purpose of the present study was to test the hypothesis that reduced uterine perfusion pressure during late pregnancy is associated with impaired endothelium-dependent vascular relaxation and, consequently, enhanced systemic vascular reactivity. Active stress was measured in aortic strips isolated from late pregnant Sprague-Dawley rats and a hypertensive pregnant rat model produced through the long-term reduction in uterine perfusion pressure (RUPP). Phenylephrine (Phe, 10-5 mol/L) caused an increase in active stress to 4.5±0.4x103 N/m2 in normal pregnant rats and a larger increase to 9.4±0.7x103 N/m2 in RUPP rats. Removal of the endothelium significantly enhanced Phe-induced stress in pregnant (6.4±0.6x103 N/m2) but not RUPP (9.95±0.95x103 N/m2) rats. In endothelium-intact strips, acetylcholine (ACh) was more potent in inducing relaxation of Phe contraction in pregnant (ED50 0.1x10-6 mol/L) than in RUPP (ED50 1.2x10-6 mol/L) rats. Pretreatment of endothelium-intact strips with NG-nitro-L-arginine methyl ester(100 µmol/L), to inhibit nitric oxide (NO) synthase, significantly inhibited ACh-induced relaxation and enhanced Phe-induced stress in pregnant (6.2±0.5x103 N/m2) but not RUPP (9.5±0.85x103 N/m2) rats. Pretreatment of endothelium-intact strips with methylene blue (10 µmol/L), to inhibit cGMP production in smooth muscle, also inhibited ACh-induced relaxation and enhanced Phe-induced stress in pregnant (6.9±0.65x103 N/m2) but not RUPP (9.3±0.7x103 N/m2) rats. In endothelium-denuded strips, relaxation of Phe contraction with the exogenous NO donor sodium nitroprusside was not significantly different between pregnant and RUPP rats. These results suggest that an endothelium-dependent relaxation pathway involving the release of NO from endothelial cells and increased cGMP production in smooth muscle is inhibited in systemic vessels of late pregnant rats with reduced uterine perfusion pressure and may in part explain the increased vascular resistance in pregnancy-induced hypertension.


Key Words: arteries • blood pressure • endothelium • nitric oxide • muscle, smooth, vascular


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Normal pregnancy is often associated with reduction in systemic vascular resistance and arterial blood pressure and decreased vascular reactivity to circulating vasoconstrictors.1 2 3 4 The hemodynamic and vascular changes observed during normal pregnancy have been explained in part by increased nitric oxide (NO) synthesis by various cells, including vascular endothelial cells.5 6 7 8 9 This is supported by reports that the metabolic production and plasma level of cGMP, a second messenger of NO and a cellular mediator of vascular smooth muscle relaxation,10 11 are increased during pregnancy.12

In 5% to 7% of pregnancies, women develop a condition called preeclampsia that is characterized by increased intravascular coagulation, proteinuria, increased systemic vascular resistance, and pregnancy-induced hypertension.13 14 Although pregnancy-induced hypertension is a major cause of maternal and fetal death, the exact mechanism of this disorder has not yet been clearly identified. Because of the difficulty of performing mechanistic studies in pregnant women, several animal models of pregnancy-induced hypertension have been developed.4 15 16 17 18 Studies in these animal models have proposed that a reduction in the uteroplacental blood flow and the ensuing placental ischemia during late pregnancy are associated with placental release of cytokines, which eventually leads to increased systemic vascular resistance and pregnancy-induced hypertension15 17 ; however, the intermediary cellular mechanisms involved are still unclear.

In the present study, we used a pregnant rat model with reduced uterine perfusion pressure (RUPP), which was produced by clipping the lower abdominal aorta and the main uterine branches of both the right and left ovarian arteries during late pregnancy, to test the central hypothesis that localized reduction in uterine perfusion pressure during late pregnancy is associated with generalized impaired endothelium-dependent vascular relaxation and, consequently, enhanced systemic vascular reactivity. The purpose of the study was (1) to determine whether vascular reactivity is enhanced in pregnant rats with RUPP compared with normal pregnant rats, (2) to determine whether endothelium-dependent vascular relaxation is inhibited in RUPP rats compared with normal pregnant rats, and (3) to determine whether the pregnancy-associated reduction in vascular relaxation and enhancement of vascular reactivity involve alterations in the endothelium-dependent NO-cGMP pathway.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animals
Time pregnant (day 12) female Sprague-Dawley rats (10 to 12 weeks of age) were purchased from Harlan Sprague-Dawley Inc, housed individually in the animal facility, and maintained on ad libitum standard rat chow and tap water on a 12-hour light/dark cycle. All procedures were performed in accordance with the guidelines of the Animal Care and Use Committee of the University of Mississippi Medical Center and the American Physiological Society.

Protocol for RUPP
On day 14 of pregnancy, pregnant rats destined to be in the RUPP group were anesthetized with isoflurane, the abdominal cavity was opened via a midline incision, the lower abdominal aorta was exposed, and a silver clip (0.203 mm ID) was placed around the aorta above the iliac bifurcation. This procedure has been shown to reduce uterine perfusion pressure in the gravid rat by {approx}40%.15 Because compensation of blood flow to the placenta occurs in pregnant rats through an adaptive increase in ovarian blood flow,19 a silver clip (0.229 mm ID) was also placed on the main uterine branches of both the right and left ovarian arteries. Control pregnant rats underwent sham surgery. Arterial catheters were placed in the carotid artery for the measurement of mean arterial pressure in conscious rats with a pressure transducer.

With the use of this protocol, the RUPP rats showed proteinuria, as indicated by increased urinary protein excretion; impaired renal function, as indicated by reduction in glomerular filtration rate and renal plasma flow; and decreased litter size and pup weight, as previously described.20 RUPP rats in which the clipping procedure resulted in maternal death or total reabsorption of the fetuses were excluded from the study.

Tissue Preparation
On the day of the experiment (day 19 to 20 of gestation), the rats were terminally anesthetized through the inhalation of isoflurane. The thoracic aorta was rapidly excised, placed in oxygenated Krebs’ solution, and cleaned of connective tissue. The aorta was cut transversely into 3-mm-wide rings. Aortic rings were cut open into strips. For endothelium-intact aortic strips, extreme care was taken throughout the procedure to avoid injury of the endothelium. For endothelium-denuded aortic strips, the endothelium was removed by gently rubbing the vessel interior with wet filter paper.

Isometric Tension
One end of the aortic strip was attached to a glass hook with the use of a thread loop, and the other end was connected to a Grass force transducer (FT03; Astro-Med). Aortic strips were stretched to Lmax (1.5-fold the unloaded initial length, L). Lmax was measured separately in aortic strips of normal pregnant and RUPP rats and did not differ significantly between normal pregnant rats and RUPP rats. Aortic strips were allowed to equilibrate for 1 hour in a water-jacketed, temperature-controlled tissue bath filled with 50 mL Krebs’ solution continuously bubbled with 95% O2/5% CO2 at 37°C. The changes in isometric tension were recorded on a Grass polygraph (model 7D; Astro-Med).

A control contraction was elicited by applying phenylephrine (Phe, 10-5 mol/L) to the tissue bath solution. Once the Phe contraction reached a plateau, the tissue was rinsed with Krebs’ solution 3 times for 10 minutes each. The entire procedure of contraction and washing was repeated 2 times. Increasing concentrations of Phe were applied, the contractile responses were recorded, and concentration-response curves were constructed.

In other tissues, a contraction was elicited in response to submaximal concentration of Phe (3x10-7 mol/L). Increasing concentrations of acetylcholine (ACh) or sodium nitroprusside were added, and the extent of vascular relaxation was measured. In other experiments, the tissues were pretreated for 30 minutes with NG-nitro-L-arginine methyl ester (L-NAME, 100 µmol/L), to inhibit NO synthase, or with methylene blue (10 µmol/L), to inhibit cGMP production in smooth muscle, and the effects were observed on the Phe-induced contraction and on the ACh-induced relaxation of Phe contraction.

Solutions, Drugs, and Chemicals
Normal Krebs’ solution contained (in mmol/L) NaCl 120, KCl 5.9, NaHCO3 25, NaH2PO4 1.2, dextrose 11.5, MgCl2 1.2, and CaCl2 2.5, at pH 7.4. Stock solutions of L-Phe HCl, ACh, bradykinin, sodium nitroprusside, L-NAME, and methylene blue (Sigma) were prepared in distilled water. All other chemicals were of reagent grade or better.

Statistical Analysis
The developed force was corrected for the cross-sectional area of each individual strip and expressed as active stress (N/m2) according to the equation: Stress=force/cross-sectional area, where cross sectional area is wet weight/(tissue densityxlength of the strip), and tissue density is 1.055 g/cm3. Data were analyzed and expressed as the mean±SEM, with n values representing the total number of experiments performed on individual aortic strips isolated from 5 to 10 different rats of each group. Data were compared with the use of ANOVA with 3 classification criteria (rat type [normal pregnant versus RUPP], condition of endothelium [intact versus denuded], and treatment [untreated versus pretreated with L-NAME or methylene blue]). Scheffé’s F test was used for comparison of multiple mean values. Student’s t test for unpaired data was used for a comparison of 2 mean values. Differences were considered statistically significant at a value of P<0.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
On the day of the experiment (day 19 to 20 of gestation), the recorded mean arterial blood pressure in control pregnant rats was as low as 88 mm Hg in some rats and as high as 103 mm Hg in other rats, with an average mean arterial pressure in the entire group of 96±2 mm Hg (n=8). The individual and the average arterial pressures in RUPP rats were consistently greater than those in the control pregnant rats. In RUPP rats, the recorded arterial pressure was as low as 106 mm Hg in some rats and as high as 140 mm Hg in other rats, with an average arterial pressure in the entire group of 126±8 mm Hg (n=10).

In the aortic strips of both pregnant and RUPP rats, Phe caused concentration-dependent increases in active stress. In endothelium-intact strips, the Phe concentration-active stress curve in RUPP rats was enhanced compared with that in normal pregnant rats (Figure 1A). The maximal Phe-induced active stress in RUPP rats (9.4±0.7x103 N/m2, n=32) was significantly greater than that in normal pregnant rats (4.5±0.4x103 N/m2, n=18). Removal of the endothelium significantly enhanced the Phe-induced stress in normal pregnant rats to a maximum of 6.4±0.6x103 N/m2 (n=24). In contrast, removal of the endothelium caused slight but insignificant increase in Phe-induced stress to a maximum of 9.95±0.95x103 N/m2 (n=24) in RUPP rats (Figure 1A). When the Phe response was presented as a percent of the maximum Phe contraction, the ED50 value for Phe in endothelium-intact aortic strips of pregnant rats was 3.5±0.4x 10-8 mol/L (n=18) (Figure 1B). Phe was markedly more potent in causing contraction in endothelium-denuded aortic strips of pregnant rats (ED50 1.4±0.2x10-8 mol/L, n=24) than in endothelium-intact strips of pregnant rats. In contrast, Phe was only slightly more potent in causing contraction in endothelium-denuded aortic strips of RUPP rats (ED50 2.0±0.2x10-8 mol/L, n=24) than in endothelium-intact strips of RUPP rats (ED50 2.6±0.3x10-8 mol/L, n=32) (Figure 1C).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 1. Phe-induced contraction in normal pregnant (Preg) and RUPP rats. Endothelium-intact (+Endo) and endothelium-denuded (-Endo) rat aortic strips were incubated in normal Krebs’ solution (2.5 mmol/L Ca2+) and then stimulated with increasing concentrations of Phe. Phe contraction was measured and presented as active stress (A) or percent of maximum Phe contraction (B and C). Data points represent mean±SEM of measurements in 18 to 32 aortic strips from 6 to 8 rats of each group.

In endothelium-intact strips, pretreatment with L-NAME (100 µmol/L) for 30 minutes, to inhibit NO synthase, significantly enhanced the Phe-induced stress in pregnant rats to a maximum of 6.2±0.5x103 N/m2 (n=32) (Figure 2A). In addition, in L-NAME–pretreated aortic strips of pregnant rats, Phe was more potent in causing contraction (ED50 1.2±0.3x10-8 mol/L, n=32) than in untreated strips of pregnant rats (Figure 2C). In contrast, in L-NAME–pretreated aortic strips of RUPP rats, the maximal Phe-induced stress (9.5±0.85x103 N/m2, n=24) and the ED50 value of Phe (2.1±0.2x10-8 mol/L, n=24) were not significantly different from those in untreated aortic strips of RUPP rats (Figures 2B and 2D).



View larger version (29K):
[in this window]
[in a new window]
 
Figure 2. Effect of L-NAME and methylene blue (Meth Blue) on Phe-induced contraction in endothelium-intact aortic strips of normal pregnant (Preg) and RUPP rats. Rat aortic strips incubated in normal Krebs’ solution (2.5 mmol/L Ca2+) were either untreated or pretreated with L-NAME (100 µmol/L) or methylene blue (10 µmol/L) for 30 minutes and then stimulated with increasing concentrations of Phe. Phe contraction was measured and presented as active stress (A and B) or percent of maximum Phe contraction (C and D). Data points represent mean±SEM of measurements in 18 to 32 aortic strips from 6 to 8 rats of each group.

Similarly, in endothelium-intact strips, pretreatment with methylene blue (10 µmol/L) for 30 minutes, to inhibit cGMP production in smooth muscle,11 enhanced Phe-induced stress in normal pregnant rats to a maximum of 6.9±0.65x103 N/m2 (n=24) (Figure 2A). In addition, in methylene blue–pretreated aortic strips of normal pregnant rats, Phe was more potent in causing contraction (ED50 1.6±0.2x10-8 mol/L, n=24) than in untreated aortic strips (Figure 2C). In contrast, in methylene blue–pretreated aortic strips of RUPP rats, the maximal Phe-induced stress (9.3±0.7x103 N/m2, n=29) and the ED50 value of Phe (2.0±0.2x10-8 mol/L, n=29) were not significantly different from those in untreated aortic strips of RUPP rats (Figures 2B and 2D).

In endothelium-intact aortic strips of both normal pregnant and RUPP rats, ACh caused concentration-dependent relaxation of Phe (3x10-7 mol/L)-induced contraction. The ACh-induced relaxation of Phe contraction was significantly greater in normal pregnant rats than in RUPP rats (Figure 3A). Similarly, bradykinin (10-7 mol/L) caused 38.6±2.7% relaxation of Phe (3x10-7 mol/L)-induced contraction in aortic strips of normal pregnant rats compared with only 9.7±1.9% relaxation in aortic strips of RUPP rats. When the ACh-induced response was presented as a percent of the maximal ACh-induced relaxation, ACh was more potent in inducing relaxation in normal pregnant rats (ED50 0.1±0.04x10-6 mol/L, n=22) than in RUPP rats (ED50 1.2±0.06x10-6 mol/L, n=18) (Figure 2B). Because the aortic strips of RUPP rats showed greater vascular reactivity than those of normal pregnant rats, control experiments were performed on strips from RUPP rats in which the initial Phe concentration was lowered to 1x10-7 mol/L to produce a submaximal contraction that is roughly equal in magnitude to the contraction observed in strips of normal pregnant rats precontracted with 3x10-7 mol/L Phe. These experiments showed that the ED50 value of ACh in aortic strips of RUPP rats precontracted with 1x10-7 mol/L Phe (1.1±0.07x10-6 mol/L) was not significantly different from that in strips precontracted with 3x10-7 mol/L Phe (1.2±0.06x10-6 mol/L). Pretreatment of endothelium-intact strips with L-NAME (100 µmol/L) or methylene blue (10 µmol/L) significantly inhibited the ACh-induced relaxation of Phe contraction in normal pregnant rats but not in RUPP rats (Figure 3A). Removal of the endothelium completely inhibited the ACh-induced relaxation of Phe contraction in both normal pregnant and RUPP rats.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3. ACh-induced relaxation of Phe (3x10-7 mol/L) contraction in endothelium-intact aortic strips of normal pregnant (Preg) and RUPP rats untreated or pretreated with L-NAME (100 µmol/L) or methylene blue (Meth Blue; 10 µmol/L) for 30 minutes. Phe (3x10-7 mol/L) contraction was elicited, and then increasing concentrations of ACh were added and relaxation was measured as percent of initial Phe contraction (A) or percent of maximal ACh-induced relaxation (B). Data points represent mean±SEM of measurements in 10 to 22 aortic strips from 5 to 10 rats of each group.

In endothelium-denuded aortic strips of both normal pregnant and RUPP rats, sodium nitroprusside, an exogenous NO donor and a standard guanylate cyclase activator,10 caused concentration-dependent relaxation of Phe contraction. However, no significant differences in the magnitude of sodium nitroprusside–induced relaxation of Phe contraction were observed between aortic strips of control pregnant rats and RUPP rats (Figure 4).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 4. Effect of sodium nitroprusside (SNP) on Phe (3x10-7 mol/L) contraction in endothelium-denuded (-Endo) aortic strips of normal pregnant (Preg) and RUPP rats. Phe (3x10-7 mol/L) contraction was elicited, and then increasing concentrations of sodium nitroprusside were added and relaxation was measured as percent of initial Phe contraction (A) or percent of maximal SNP-induced relaxation (B). Data points represent mean±SEM of measurements in 6 to 9 aortic strips from 6 rats of each group.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The main findings of the present study are that (1) the mean arterial pressure in late pregnant rats with RUPP is significantly greater than that in normal pregnant rats, (2) vascular reactivity is greater in RUPP rats than in normal pregnant rats, (3) endothelium-dependent vascular relaxation is less in RUPP rats than in normal pregnant rats, and (4) the activity of an endothelium-dependent NO-cGMP pathway is reduced in RUPP rats compared with normal pregnant rats.

We and others2 3 4 have previously shown that the mean arterial pressure and the vascular reactivity to various vasoconstrictors are reduced in pregnant rats compared with virgin rats. On the other hand, the present study showed that the mean arterial pressure, as well as the vascular reactivity in response to the {alpha}-adrenergic agonist Phe, is enhanced in a pregnant rat model of RUPP compared with normal pregnant rat. These findings in the RUPP rat are consistent with previous studies from our laboratory and others that have shown that the arterial blood pressure and the vascular reactivity in response to vasoconstrictors are enhanced in other animal models of hypertension during late pregnancy.1 4 16 21 22 In search for the possible intermediary cellular mechanisms involved in the observed enhanced vascular reactivity in the RUPP rat, we found that removal of the endothelium significantly enhanced the Phe contraction in normal pregnant rats but had minimal effects in RUPP rats. In addition, the ACh-induced relaxation was less in RUPP rats than in normal pregnant rats. These results suggest that an endothelium-dependent relaxation pathway is intact in normal pregnant rats but possibly impaired in the RUPP rats.

The vascular endothelium releases several vasodilators, including endothelium-derived relaxing factor, and several studies have suggested that endothelium-derived relaxing factor is NO.23 24 25 26 The reduced ACh-induced relaxation in RUPP rats could be due either to a decrease in the synthesis and release of NO from endothelial cells or to a change in the sensitivity of vascular smooth muscle to relaxation by NO. The sensitivity of vascular smooth muscle to relaxation by NO could be evaluated on the basis of its sensitivity to relaxation by exogenous NO donors such as sodium nitroprusside. The observation that relaxation of endothelium-denuded vascular strips by sodium nitroprusside was not significantly different for normal pregnant and RUPP rats provided evidence that the endothelium-independent mechanisms of vascular relaxation and the sensitivity of vascular smooth muscle to relaxation by NO are not impaired in RUPP rats and thereby suggest that the impaired ACh-induced relaxation in RUPP rats is most likely due to a decrease in the synthesis or release (or both) of NO from endothelial cells.

To further investigate the possible role of NO synthesis and release in the proposed impaired endothelium-dependent relaxation pathway in the RUPP rats, we found that pretreatment of the vascular strips with L-NAME, which is known to block NO synthesis, significantly inhibited vascular relaxation by ACh and significantly enhanced the vascular reactivity to Phe in normal pregnant rats but had minimal effects in RUPP rats. These results suggest that NO synthesis by endothelial cells is intact in pregnant rats but is significantly impaired during reduction of uterine perfusion pressure in late pregnant rats.

The NO produced by endothelial cells is known to promote vascular relaxation by activating guanylate cyclase and increasing cGMP production in vascular smooth muscle.26 We found that methylene blue, which is known to inhibit guanylate cyclase and to decrease cGMP production in smooth muscle,11 significantly inhibited the endothelium-dependent vascular relaxation by ACh and significantly enhanced the vascular reactivity to Phe in endothelium-intact strips of normal pregnant rats but not RUPP rats. These results further support the hypothesis that NO production or release by endothelial cells, and thereby the activity of the NO-cGMP pathway in vascular smooth muscle, is reduced in RUPP rats compared with normal pregnant rats. However, the results of the methylene blue experiments should be interpreted with caution because methylene blue may also inhibit NOS.

It is important to emphasize the following cautionary remarks regarding the above interpretations. First, although the present results suggest that the decrease in endothelial cell function and the increase in vascular reactivity observed in the RUPP rats could contribute to the observed increase in blood pressure, these results should be interpreted with caution because the changes in endothelial cell function and vascular reactivity may also be secondary to blood pressure elevation. An analysis of the time course of the changes in vascular reactivity and the increase in blood pressure should help determine whether the relationship between these 2 parameters is causal or associative in nature and should, therefore, represent an important area for future investigations. Second, the vascular endothelium has been shown to release other vasodilator substances, in addition to NO, such as endothelium-derived hyperpolarizing factor and prostacyclin.27 This may explain why in the aortic strips of RUPP rats, some relaxation to ACh was still observed and was not completely inhibited by L-NAME or methylene blue. On the other hand, the complete absence of ACh-induced relaxation in endothelium-denuded strips of RUPP rats still supports the contention that the ACh-induced relaxation is endothelium dependent. Third, although the present results provided evidence that the enhanced vascular reactivity in the RUPP rats may involve inhibition of an endothelium-dependent NO-cGMP pathway, we cannot rule out the possibility that an increase in the release of contracting factors from the endothelium or an increase in the sensitivity of vascular smooth muscle to endothelium-derived contracting factors also occurs. This is supported by a recent report that long-term inhibition of NO synthesis during mid to late gestation in rats is associated with elevated plasma levels of endothelin-1.28 This is also supported by the present observation that removal of the endothelium or pretreatment of aortic strips of the normal pregnant rats with L-NAME or methylene blue caused an enhancement of Phe-induced vascular reactivity to levels that were still less than that observed in the RUPP rats. Thus, the reduction in uterine perfusion pressure during late pregnancy in rats may be associated with additional alterations in the cellular mechanisms of vascular smooth muscle contraction and should be an interesting area for future experiments. Fourth, because the present study was performed on strips of thoracic aorta, we cannot make a definite conclusion regarding whether the observed changes in vascular reactivity also occur in resistance vessels, which should represent an important area for future investigations.

The question remains of how a localized reduction in uterine perfusion pressure during late pregnancy would cause generalized impaired endothelium-dependent vascular relaxation, and consequently, enhanced systemic vascular reactivity. It has been hypothesized that reduction in the uteroplacental blood flow and the ensuing placental ischemia during late pregnancy may be associated with placental release of cytokines, which may then cause generalized endothelial cell damage.29 30 This is supported by recent reports that cytokines such as tumor necrosis factor-{alpha} significantly depress endothelium-dependent vascular relaxation.31 This is also supported by preliminary observations from our laboratory suggesting that chronic infusion of tumor necrosis factor-{alpha} is associated with increased vascular resistance and arterial pressure in late pregnant rats.32

In conclusion, the present results suggest that an endothelium-dependent relaxation pathway involving the production and release of NO from endothelial cells and increased cGMP production in smooth muscle is inhibited in a pregnant rat model of RUPP. The RUPP rat could be useful as an animal model for a specific form of hypertension associated with endothelial dysfunction and should be helpful in understanding the cellular mechanisms of the increased vascular resistance in pregnancy-induced hypertension.


*    Acknowledgments
 
This work was supported by a grant-in-aid from the American Heart Association, Mississippi Affiliate, and by National Heart, Lung, and Blood Institute grants HL-52696, HL-33849, and HL-51971.

Received September 14, 1999; first decision October 11, 1999; accepted October 19, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Molnar M, Hertelendy F. NG-Nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy induced refractoriness to vasopressor agents. Am J Obstet Gynecol. 1992;166:1560–1567.[Medline] [Order article via Infotrieve]

2. Duvekot JJ, Peeters LL. Renal hemodynamics and volume homeostasis in pregnancy. Obstet Gynecol Surv. 1994;49:830–839.[Medline] [Order article via Infotrieve]

3. Nathan L, Cuevas J, Chaudhuri G. The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol. 1995;114:955–960.[Medline] [Order article via Infotrieve]

4. Khalil RA, Crews JK, Novak J, Kassab S, Granger JP. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension. 1998;31:1065–1069.[Abstract/Free Full Text]

5. Parent A, Schiffrin EL, St-Louis J. Role of the endothelium in adrenergic responses of mesenteric artery rings of pregnant rats. Am J Obstet Gynecol. 1990;163:229–234.[Medline] [Order article via Infotrieve]

6. Ahokas RA, Mercer BM, Sibai BM. Enhanced endothelium-derived relaxing factor activity in pregnant, spontaneously hypertensive rats. Am J Obstet Gynecol. 1991;165:801–807.[Medline] [Order article via Infotrieve]

7. Davidge ST, McLaughlin MK. Endogenous modulation of the blunted adrenergic response in resistance-sized mesenteric arteries from the pregnant rat. Am J Obstet Gynecol. 1992;167:1691–1698.[Medline] [Order article via Infotrieve]

8. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol. 1997;272:R441–R463.[Abstract/Free Full Text]

9. Williams DJ, Vallance PJ, Neild GH, Spencer JA, Imms FJ. Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol. 1997;272:H748–H752.[Abstract/Free Full Text]

10. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ. Relationship between cyclic guanosine 3',5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther. 1981;219:181–186.[Abstract/Free Full Text]

11. Ignarro LJ, Kadowitz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol. 1985;25:171–191.[Medline] [Order article via Infotrieve]

12. Conrad KP, Vernier KA. Plasma levels, urinary excretion and metabolic production of cGMP during gestation in rats. Am J Physiol. 1989;257:R847–R853.[Abstract/Free Full Text]

13. Friedman SA, Lubarsky SL, Ahokas RA, Nova A, Sibai BM. Preeclampsia and related disorders: clinical aspects and relevance of endothelin and nitric oxide. Clin Perinatol. 1995;22:343–355.[Medline] [Order article via Infotrieve]

14. Morris NH, Eaton BM, Dekker G. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol. 1996;103:4–15.[Medline] [Order article via Infotrieve]

15. Eder DJ, McDonald MT. A role for brain angiotensin II in experimental pregnancy-induced hypertension in laboratory rats. Clin Exp Hyper Hyper Preg. 1987;B6:431–451.

16. Conrad KP. Animal models of pre-eclampsia: do they exist? Fetal Med Rev. 1990;2:67–88.

17. Losonczy G, Brown G, Venuto RC. Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits. Am J Med Sci. 1992;303:233–240.[Medline] [Order article via Infotrieve]

18. Baylis C, Suto T, Conrad K. Importance of nitric oxide in control of systemic and renal hemodynamics during normal pregnancy: studies in the rat and implications for preeclampsia. Hypertens Preg. 1996;15:147–169.

19. Nienartowicz A, Link S, Moll W. Adaptation of the uterine arcade in rats to pregnancy. J Dev Physiol. 1989;12:101–108.[Medline] [Order article via Infotrieve]

20. Alexander BT, Kassab SE, Abrams SR, Reckelhoff JF, Granger JP. Renal protein expression of neuronal NOS is reduced in a rat model of pregnancy-induced hypertension. Hypertension. 1999;34:368. Abstract.

21. Crews JK, Novak J, Granger JP, Khalil RA. Stimulated mechanisms of Ca2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats. Am J Physiol. 1999;276:R530–R538.

22. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994;170:1458–1466.[Medline] [Order article via Infotrieve]

23. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376.[Medline] [Order article via Infotrieve]

24. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524–526.[Medline] [Order article via Infotrieve]

25. Moncada S, Palmer RM, Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 1988;12:365–372.[Abstract/Free Full Text]

26. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989;65:1–21.[Free Full Text]

27. Vanhoutte PM. Vascular biology: old-timer makes a comeback. Nature. 1998;396:213, 215–216.[Medline] [Order article via Infotrieve]

28. Edwards DL, Arora CP, Bui DT, Castro LC. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1. Am J Obstet Gynecol. 1996;175:484–488.[Medline] [Order article via Infotrieve]

29. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84:937–940.[Medline] [Order article via Infotrieve]

30. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998;40:102–111.

31. Wang P, Ba ZF, Chaudry IH. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol. 1994;266:H2535–H2541.[Abstract/Free Full Text]

32. Granger JP, Bennett WA, Alexander BT, Cockrell KL, Whitwhorth NS. Long-term elevation of plasma TNF-{alpha} increases arterial pressure and reduces kidney function in pregnant rats. Hypertension. 1999;34:337. Abstract.




This article has been cited by other articles:


Home page
HypertensionHome page
S. K. Walsh, F. A. English, E. J. Johns, and L. C. Kenny
Plasma-Mediated Vascular Dysfunction in the Reduced Uterine Perfusion Pressure Model of Preeclampsia: A Microvascular Characterization
Hypertension, August 1, 2009; 54(2): 345 - 351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. K. Stennett, X. Qiao, A. E. Falone, V. V. Koledova, and R. A. Khalil
Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H745 - H755.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. Chen and R. A. Khalil
Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1962 - R1972.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. D. LaMarca, J. Gilbert, and J. P. Granger
Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia
Hypertension, April 1, 2008; 51(4): 982 - 988.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger
Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H541 - H550.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Verlohren, M. Niehoff, L. Hering, N. Geusens, F. Herse, A. N. Tintu, A. Plagemann, F. LeNoble, R. Pijnenborg, D. N. Muller, et al.
Uterine Vascular Function in a Transgenic Preeclampsia Rat Model
Hypertension, February 1, 2008; 51(2): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. S. Gilbert, S. A. Babcock, and J. P. Granger
Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression
Hypertension, December 1, 2007; 50(6): 1142 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. M. Sholook, J. S. Gilbert, M. H. Sedeek, M. Huang, R. L. Hester, and J. P. Granger
Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2080 - H2084.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. P. Granger
Response to Modeling Preeclampsia: The True Model for the Uniquely Human Disease Preeclampsia Is the Human Female Not the Pregnant Rat
Hypertension, April 1, 2007; 49(4): e22 - e22.
[Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. M. Anderson, F. Lopez, H.-Y. Zhang, Y. Shirasawa, K. Pavlish, and J. N. Benoit
Mesenteric Vascular Responsiveness in a Rat Model of Pregnancy-Induced Hypertension
Experimental Biology and Medicine, September 1, 2006; 231(8): 1398 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. M. Anderson, F. Lopez, H.-Y. Zhang, K. Pavlish, and J. N. Benoit
Reduced Uteroplacental Perfusion Alters Uterine Arcuate Artery Function in the Pregnant Sprague-Dawley Rat
Biol Reprod, March 1, 2005; 72(3): 762 - 766.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Myers, G. Mires, M. Macleod, and P. Baker
In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease
Hypertension, February 1, 2005; 45(2): 258 - 263.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. Cherla and E. A. Jaimes
Role of L-Arginine in the Pathogenesis and Treatment of Renal Disease
J. Nutr., October 1, 2004; 134(10): 2801S - 2806S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Orshal and R. A. Khalil
Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1013 - R1023.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. T. Alexander, M. T. Llinas, W. C. Kruckeberg, and J. P. Granger
L-Arginine Attenuates Hypertension in Pregnant Rats With Reduced Uterine Perfusion Pressure
Hypertension, April 1, 2004; 43(4): 832 - 836.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. M. Orshal and R. A. Khalil
Reduced Endothelial NO-cGMP-Mediated Vascular Relaxation and Hypertension in IL-6-Infused Pregnant Rats
Hypertension, February 1, 2004; 43(2): 434 - 444.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. A. Payne, B. T. Alexander, and R. A. Khalil
Decreased Endothelium-Dependent NO-cGMP Vascular Relaxation and Hypertension in Growth-Restricted Rats on a High-Salt Diet
Hypertension, February 1, 2004; 43(2): 420 - 427.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. A. Payne, B. T. Alexander, and R. A. Khalil
Reduced Endothelial Vascular Relaxation in Growth-Restricted Offspring of Pregnant Rats With Reduced Uterine Perfusion
Hypertension, October 1, 2003; 42(4): 768 - 774.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. Martinez-Orgado, R. Gonzalez, S. Tovar, J. Marin, M. Salaices, and M. J. Alonso
Administration of N{omega}-L-Arginine Methyl Ester (L-NAME) Impairs Endothelium-Dependent Relaxation in Gravid But Not Nongravid Rats
Reproductive Sciences, February 1, 2003; 10(2): 74 - 81.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. G. Murphy, J. N. Herrington, J. P. Granger, and R. A. Khalil
Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H393 - H403.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. A. Khalil and J. P. Granger
Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R29 - R45.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. B. Giardina, G. M. Green, K. L. Cockrell, J. P. Granger, and R. A. Khalil
TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R130 - R143.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. R. Davis, J. B. Giardina, G. M. Green, B. T. Alexander, J. P. Granger, and R. A. Khalil
Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha -induced hypertension in pregnant rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R390 - R399.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. B. Giardina, K. L. Cockrell, J. P. Granger, and R. A. Khalil
Low-Salt Diet Enhances Vascular Reactivity and Ca2+ Entry in Pregnant Rats With Normal and Reduced Uterine Perfusion Pressure
Hypertension, February 1, 2002; 39(2): 368 - 374.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. A. Barron, J. B. Giardina, J. P. Granger, and R. A. Khalil
High-Salt Diet Enhances Vascular Reactivity in Pregnant Rats With Normal and Reduced Uterine Perfusion Pressure
Hypertension, September 1, 2001; 38(3): 730 - 735.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. BOHLENDER, D. GANTEN, and F. C. LUFT
Rats Transgenic for Human Renin and Human Angiotensinogen as a Model for Gestational Hypertension
J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2056 - 2061.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crews, J. K.
Right arrow Articles by Khalil, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crews, J. K.
Right arrow Articles by Khalil, R. A.
Related Collections
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Hypertension - basic studies
Right arrow Endothelium/vascular type/nitric oxide